Clinical Trial Update: Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial compares exemestane with tamoxifen in women with locally recurrent or metastatic breast cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Exemestane (Exemestane)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED